| Today's News and Trends | Caristo Diagnostics, an Oxford-based medtech company founded by cardiologists, has gained FDA clearance for its CaRi-Plaque technology. Caristo Diagnostics, an Oxford-based medtech company founded by cardiologists, has gained FDA clearance for its CaRi-Plaque technology. | | |
| A Florida family is suing Mayo Clinic for allegedly performing a heart transplant without communicating certain risks associated with the donated organ. Mayo Clinic has pushed back against those claims, saying it acted appropriately every step of the way. A Florida family is suing Mayo Clinic for allegedly performing a heart transplant without communicating certain risks associated with the donated organ. Mayo Clinic has pushed back against those claims, saying it acted appropriately every step of the way. | | |
| The donor-derived cell-free DNA tests from CareDx are designed to limit the use of surveillance biopsies and other more invasive treatment options. These tests have been available for adult patients for years now. The donor-derived cell-free DNA tests from CareDx are designed to limit the use of surveillance biopsies and other more invasive treatment options. These tests have been available for adult patients for years now. | | |
| | A new spending proposal that would extend government funding for another seven months does not address the Medicare payment cut that went into effect on Jan. 1. More than 100 healthcare groups, including the ACC, STS, SCCT and SCAI, are now voicing their disappointment. A new spending proposal that would extend government funding for another seven months does not address the Medicare payment cut that went into effect on Jan. 1. More than 100 healthcare groups, including the ACC, STS, SCCT and SCAI, are now voicing their disappointment. | | |
| TAVR is associated with a significantly lower risk of bioprosthetic valve dysfunction than SAVR, according to new data presented at CRT 2025 and simultaneously published in JACC. TAVR is associated with a significantly lower risk of bioprosthetic valve dysfunction than SAVR, according to new data presented at CRT 2025 and simultaneously published in JACC. | | |
| Researchers presented new two-year data from the SMART trial at CRT 2025 in Washington, D.C. Overall, self-expanding TAVR valves continue to show superior valve performance compared to balloon-expandable valves, and clinical outcomes remain comparable. Researchers presented new two-year data from the SMART trial at CRT 2025 in Washington, D.C. Overall, self-expanding TAVR valves continue to show superior valve performance compared to balloon-expandable valves, and clinical outcomes remain comparable. | | |
| | Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke. Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke. | | |
| Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement. Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement. | | |
| How safe is it to perform cardiac surgery on a pregnant patient? When should care teams try to deliver the baby first and then complete the procedure? A team of Mayo Clinic researchers addressed those very questions, and many others, in a new analysis. How safe is it to perform cardiac surgery on a pregnant patient? When should care teams try to deliver the baby first and then complete the procedure? A team of Mayo Clinic researchers addressed those very questions, and many others, in a new analysis. | | |
| | Experts note that multimodal GenAI presents a “transformative opportunity” to increase the efficiency and accuracy of radiologist reporting. Experts note that multimodal GenAI presents a “transformative opportunity” to increase the efficiency and accuracy of radiologist reporting. | | |
| Per a media report, employees received the offer via email on Friday. No official layoffs have been announced. Per a media report, employees received the offer via email on Friday. No official layoffs have been announced. | | |
| |
|
| ![]() | |
|
